GlassScriptPhysician profile
Alan M Reich
NPI 1932207487
$4,055.71
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,212 · 2020: $1,286 · 2021: $558.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $536.79 | 2019-2021 | |
| Lilly USA, LLC | $474.51 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $418.73 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $343.57 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $283.84 | 2019-2020 | |
| Mannkind Corporation | $265.64 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.84 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $205.19 | 2019-2021 | |
| Abbvie INC. | $168.76 | 2019-2021 | |
| Corcept Therapeutics | $149.79 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $105.93 | 2020-2021 | |
| Insulet Corporation | $95.07 | 2019 | |
| Amgen INC. | $86.86 | 2019 | |
| Valeritas, INC. | $77.76 | 2019 | |
| Lifescan, INC. | $76.16 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $68.32 | 2019-2021 | |
| Radius Health, INC. | $67.63 | 2020 | |
| Shire North American Group INC | $67.30 | 2019 | |
| Antares Pharma, INC. | $59.22 | 2019-2021 | |
| Tandem Diabetes Care, INC. | $50.99 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.75 | 2020-2021 | |
| Ibsa Pharma INC. | $43.05 | 2020 | |
| Abbott Laboratories | $41.42 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $24.98 | 2020 | |
| Horizon Therapeutics Plc | $20.83 | 2021 | |
| Aytu Biopharma, INC. | $18.45 | 2020 | |
| Arbor Pharmaceuticals, INC. | $16.28 | 2020 | |
| Companion Medical, INC. | $15.23 | 2019 | |
| Amarin Pharma, INC. | $13.82 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Reich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.